Insulet Corporation (PODD) End of Product Monopoly Case

On May 14, 2024, Blue Orca Capital announced a short position on Insulet Corporation.
In two consecutive trading sessions on May 10 and May 13, 2024, $PODD lost  $1.15B+ of shareholder value. 
Investors may have grounds to suspect Insulet of hiding material negative information about its business, which led to their losses.
Blue Orca claims that the Court of Appeals for the Federal Curcuit recently overturned a preliminary injunction that protected Insulet's monopoly on tubeless insulin delivery systems, effectively opening the market for competition.

Blue Orca expects immediate negative impact for $PODD in new competitive market.

Considering all the information, investors might have grounds to suspect Insulet of failing to disclose important facts, which led to their losses.

Case Status

Inactive Investigation

Alleged Offence

Misleading Statements,

Failure to Disclose,

Omissions

Suspected Party

Directors,

Management

Security Type

Stocks

Trade Direction

Long

Shock Event Date

05/10/2024

Trusted by industry leaders

Endorsed by top professionals who trust our innovative solutions to drive impactful results.